On January 5, 2015, the board of directors of Echo Therapeutics, Inc. appointed Scott W. Hollander, the company's president and chief executive officer, to fill a vacancy on the board. Mr. Hollander will serve as a Class I director of the company.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+11.91% | 227B | |
+15.46% | 197B | |
+18.58% | 141B | |
+30.36% | 110B | |
+0.65% | 64.15B | |
+17.74% | 53.72B | |
+5.82% | 51.75B | |
+11.23% | 45.2B | |
+5.73% | 37.37B |